Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:748-754

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuck, K.-H.
Right arrow Articles by Rüppel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuck, K.-H.
Right arrow Articles by Rüppel, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMIODARONE HYDROCHLORIDE
*METOPROLOL
Medline Plus Health Information
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Ablation/ICD/surgery
Right arrow Secondary prevention

(Circulation. 2000;102:748.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest

The Cardiac Arrest Study Hamburg (CASH)

Karl-Heinz Kuck, MD; Riccardo Cappato, MD; Jürgen Siebels, MD; Rudolf Rüppel, MD; for the CASH Investigators

From St Georg Hospital, Hamburg, Germany.

Correspondence to Karl-Heinz Kuck, MD, AK St Georg, Lohmühlenstrasse 5, 20099 Hamburg, Germany. E-mail kuck{at}uke.uni-hamburg.de

Background—We conducted a prospective, multicenter, randomized comparison of implantable cardioverter-defibrillator (ICD) versus antiarrhythmic drug therapy in survivors of cardiac arrest secondary to documented ventricular arrhythmias.

Methods and Results—From 1987, eligible patients were randomized to an ICD, amiodarone, propafenone, or metoprolol (ICD versus antiarrhythmic agents randomization ratio 1:3). Assignment to propafenone was discontinued in March 1992, after an interim analysis conducted in 58 patients showed a 61% higher all-cause mortality rate than in 61 ICD patients during a follow-up of 11.3 months. The study continued to recruit 288 patients in the remaining 3 study groups; of these, 99 were assigned to ICDs, 92 to amiodarone, and 97 to metoprolol. The primary end point was all-cause mortality. The study was terminated in March 1998, when all patients had concluded a minimum 2-year follow-up. Over a mean follow-up of 57±34 months, the crude death rates were 36.4% (95% CI 26.9% to 46.6%) in the ICD and 44.4% (95% CI 37.2% to 51.8%) in the amiodarone/metoprolol arm. Overall survival was higher, though not significantly, in patients assigned to ICD than in those assigned to drug therapy (1-sided P=0.081, hazard ratio 0.766, [97.5% CI upper bound 1.112]). In ICD patients, the percent reductions in all-cause mortality were 41.9%, 39.3%, 28.4%, 27.7%, 22.8%, 11.4%, 9.1%, 10.6%, and 24.7% at years 1 to 9 of follow-up.

Conclusions—During long-term follow-up of cardiac arrest survivors, therapy with an ICD is associated with a 23% (nonsignificant) reduction of all-cause mortality rates when compared with treatment with amiodarone/metoprolol. The benefit of ICD therapy is more evident during the first 5 years after the index event.


Key Words: heart arrest • defibrillation • cardioversion • antiarrhythmia agents • resuscitation




This article has been cited by other articles:


Home page
EuropaceHome page
L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang
Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
Europace, June 16, 2008; (2008) eun150v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. Mark Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2085 - 2105.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): 2820 - 2840.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
H. J. Wellens
Forty Years of Invasive Clinical Electrophysiology: 1967-2007
Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 49 - 53.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Sutton, J. D. Fisher, C. Linde, and D. G. Benditt
History of electrical therapy for the heart
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I3 - I10.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
T. Rossenbacker, S. G. Priori, and D. P. Zipes
The fight against sudden cardiac death: consensus guidelines as a reference
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I50 - I58.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
W. Jung and B. Schumacher
What is the role of risk stratification for sudden death in the defibrillator era?
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I59 - I65.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. Santini, C. Lavalle, and R. P. Ricci
Primary and secondary prevention of sudden cardiac death: who should get an ICD?
Heart, November 1, 2007; 93(11): 1478 - 1483.
[Full Text] [PDF]


Home page
JAMAHome page
P. Vassallo and R. G. Trohman
Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
JAMA, September 19, 2007; 298(11): 1312 - 1322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Callans
Patients With Hemodynamically Tolerated Ventricular Tachycardia Require Implantable Cardioverter Defibrillators
Circulation, September 4, 2007; 116(10): 1196 - 1203.
[Full Text] [PDF]


Home page
CirculationHome page
J. Almendral and M. E. Josephson
All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator
Circulation, September 4, 2007; 116(10): 1204 - 1212.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Singh and M. M. Murawski
Implantable Cardioverter Defibrillator Therapy and the Need for Concomitant Antiarrhythmic Drugs
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 175 - 180.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Ann Intern Med, August 21, 2007; 147(4): 251 - 262.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
CMAJHome page
D. H. Birnie MB ChB MD, C. Sambell BSc, H. Johansen PhD, K. Williams MS, R. Lemery MD, M. S. Green MD, M. H. Gollob MD, D. S. Lee MD PhD, and A. S.L. Tang MD
Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest
Can. Med. Assoc. J., July 3, 2007; 177(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
C. S. Simpson MD
Implantable cardioverter defibrillators work so why aren't we using them?
Can. Med. Assoc. J., July 3, 2007; 177(1): 49 - 51.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. S. Healey, A. P. Hallstrom, K.-H. Kuck, G. Nair, E. P. Schron, R. S. Roberts, C. A. Morillo, and S. J. Connolly
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
Eur. Heart J., July 2, 2007; 28(14): 1746 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Jahangir, D. J. Bradley, and W. K. Shen
ICDs for secondary prevention of sudden death in the older-elderly
Eur. Heart J., July 2, 2007; 28(14): 1665 - 1667.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Chugh, K. Reinier, and E. C. Stecker
Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients: Comorbidities Matter
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2416 - 2418.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Patel and J. T. Heywood
Mode of Death in Patients With Systolic Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 127 - 136.
[Abstract] [PDF]


Home page
CirculationHome page
A. E. Epstein, C. A. Baessler, A. B. Curtis, N.A. M. Estes III, B. J. Gersh, B. Grubb, and L. B. Mitchell
Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology" Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society
Circulation, March 6, 2007; 115(9): 1170 - 1176.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. K. Gehi, D. Mehta, and J. A. Gomes
Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock
JAMA, December 20, 2006; 296(23): 2839 - 2847.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
Circulation, December 19, 2006; 114(25): 2871 - 2891.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
EuropaceHome page
K.-H. Kuck and S. Nisam
ICD therapy: 'the sickest benefit the most...': what about the less sick?
Europace, July 1, 2006; 8(7): 508 - 511.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Nisam and G. Breithardt
Lessons learned from neutral ICD trials
Europace, June 1, 2006; 8(6): 393 - 397.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Z. Goldberger and R. Lampert
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
JAMA, February 15, 2006; 295(7): 809 - 818.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. R. Paisey, A. M. Yue, F. Bessoule, P. R. Roberts, and J. M. Morgan
Passive electrode effect reduces defibrillation threshold in bi-filament middle cardiac vein defibrillation.
Europace, February 1, 2006; 8(2): 113 - 117.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Abello, J. L. Merino, R. Peinado, M. Gnoatto, M. A. Arias, M. Gonzalez-Vasserot, and J. A. Sobrino
Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia
Eur. Heart J., January 1, 2006; 27(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Elhendy, S. Chapman, T. R. Porter, and J. Windle
Association of Myocardial Ischemia With Mortality and Implantable Cardioverter-Defibrillator Therapy in Patients With Coronary Artery Disease at Risk of Arrhythmic Death
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1721 - 1726.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Al-Khatib, F. L. Lucas, J. G. Jollis, D. J. Malenka, and D. E. Wennberg
The Relation Between Patients' Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries
J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1536 - 1540.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, D. C. Kambouraki, D. A. Arfanakis, and P. E. Vardas
Amino-Terminal Pro-Brain Natriuretic Peptide Predicts Ventricular Arrhythmogenesis in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Chest, October 1, 2005; 128(4): 2604 - 2610.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. Gehi, D. Haas, and V. Fuster
Primary Prophylaxis With the Implantable Cardioverter-Defibrillator: The Need for Improved Risk Stratification
JAMA, August 24, 2005; 294(8): 958 - 960.
[Full Text] [PDF]


Home page
CirculationHome page
A. Kadish and M. Mehra
Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy
Circulation, June 21, 2005; 111(24): 3327 - 3335.
[Full Text] [PDF]


Home page
CirculationHome page
M. O. Sweeney, M. S. Wathen, K. Volosin, I. Abdalla, P. J. DeGroot, M. F. Otterness, and A. J. Stark
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial
Circulation, June 7, 2005; 111(22): 2898 - 2905.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?
Circulation, May 17, 2005; 111(19): 2537 - 2549.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. S. Chan and R. A. Hayward
Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia: An Effectiveness Study
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1474 - 1481.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
R. Sukhija, W. S. Aronow, C. Sorbera, K. Yalamanchili, and M. Cohen
Patients, Mean Age 70 Years, With Automatic Implantable Cardioverter-Defibrillators Treated With Dual-Chamber Rate Responsive Pacing (DDDR-70) Have a Higher Mortality Than Patients With Backup Ventricular Pacing (VVI-40) at 3.7-Year Follow-Up
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2005; 60(5): 603 - 604.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A Y Patwala and D J Wright
Device based treatment of heart failure
Postgrad. Med. J., May 1, 2005; 81(955): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P. S Spector
Diagnosis and management of sudden cardiac death
Heart, March 1, 2005; 91(3): 408 - 413.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. W. Groeneveld, P. A. Heidenreich, and A. M. Garber
Trends in implantable cardioverter-defibrillator racial disparity: The importance of geography
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 72 - 78.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. J. Plummer, R. J. Irving, and J. M. McComb
The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district
Europace, January 1, 2005; 7(3): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
M. A. Hlatky, G. D. Sanders, and D. K. Owens
Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter Defibrillator
Health Aff., January 1, 2005; 24(1): 42 - 51.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. S. Desai, J. C. Fang, W. H. Maisel, and K. L. Baughman
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials
JAMA, December 15, 2004; 292(23): 2874 - 2879.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. Parkash, A. Tang, G. Wells, J. Blackburn, I. Stiell, C. Simpson, P. Dorian, R. Yee, D. Cameron, S. Connolly, et al.
Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study
Can. Med. Assoc. J., October 26, 2004; 171(9): 1053 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J.J. Wellens
Cardiac arrhythmias: The quest for a cure: A historical perspective
J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Voigt, R. Ezzeddine, W. Barrington, O. Obiaha-Ngwu, L. I. Ganz, B. London, and S. Saba
Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 855 - 858.
[Abstract] [Full Text] [PDF]